Source The Telegraph:
Statins could soon be prescribed to treat multiple sclerosis after a groundbreaking trial began to see if the cheap cholesterol busting drug could delay symptoms.
The £6 million project is being led by University College London and involves 1,180 people at 30 centres across Britain.
It follows a successful small trial in 2014 which showed a significant reduction in the rate of brain shrinkage and an increase in mobility after two years for people on high doses of simvastatin , which usually prescribed to lower cholesterol. Read on.